Zilade 40mg Capsules
PDF Leaflet Revision Date: 24 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of metastatic castration-resistant prostate cancer in adult men.
Dosage (summary)
160 mg (four 40 mg capsules) once daily.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in women; unknown if excreted in breast milk.
Key Drug Interactions
- CYP2C8 inhibitors/inducers
- CYP3A4 inhibitors/inducers
- QT prolonging agents
Contraindications
- Hypersensitivity to enzalutamide
- Not for use in women
Common side effects
- Asthenia/fatigue
- Hot flushes
- Headache
- Hypertension
Counselling Points
- Take whole with water
- Use contraception during and 4 months after treatment
- Monitor for seizures
Serious warnings
- Risk of seizure
- Posterior reversible encephalopathy syndrome
- QT prolongation risk
Important Disclaimer
The Zilade 40mg Capsules professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
